BrainsWay highlights growing U.S. payer support allowing psychiatric mental health nurse practitioners to administer Deep TMS therapy, expected to expand access to non-drug mental health treatments.
Key takeaways
Optum/United Behavioral Health updated TMS policy in late 2025 to allow PMHNPs to order, supervise, and administer TMS in full practice authority states, covering 34.8 million lives.
Multiple U.S. commercial payers, MACs (First Coast, National Government Services, Novitas), VA, and TRICARE West adopted similar policies increasing nurse practitioner role in TMS care.
Policy evolution aims to address psychiatrist shortages, reduce wait times, and improve patient access to Deep TMS.
BrainsWay Deep TMS has FDA clearance for major depressive disorder, OCD, and smoking addiction.
CEO Hadar Levy states changes remove barriers to proven mental health care options.